LifeX Ventures
About LifeX Ventures
LifeX Ventures is a New York-based venture capital firm investing in early-stage technology companies. The firm focuses on sectors such as technology, healthcare, life sciences, artificial intelligence, biotechnology, medical devices, digital health, pharmaceuticals, diagnostics, consumer health, climate tech, clean energy, sustainability, agriculture, and food tech. LifeX Ventures provides funding to startups at various stages, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO. The firm's geographical focus spans multiple regions, including the United States, Europe, Asia, Africa, Australia, South America, North America, Antarctica, Asia-Pacific, the Middle East, Central America, the Caribbean, Oceania, Southeast Asia, Sub-Saharan Africa, Eastern Europe, Western Europe, Northern Europe, Southern Europe, and Central Asia. LifeX Ventures has a minimum investment size of $1 million and a maximum investment size of $50 million. The firm's team comprises individuals with diverse backgrounds in technology, entrepreneurship, and investment. Notable team members include Amol Sarva, PhD, a cognitive scientist turned entrepreneur; Rika Christanto, a tech operator and entrepreneur; Yue Zhao, a CTO and CPO; Veeral Mehta, MD, a medical doctor and business development analyst; Lisa Kleinsorge, a go-to-market leader and investor; Fabian Siegel, a founder and CEO; and Inaki Berenguer, PhD, a scientist turned tech entrepreneur. These professionals bring a wealth of experience from various sectors, including technology, healthcare, and business development. LifeX Ventures is committed to supporting visionary entrepreneurs who are developing transformational solutions in their respective fields. The firm's investment philosophy centers on providing not only capital but also strategic guidance and resources to help startups navigate challenges and achieve sustainable growth. By leveraging its extensive network and expertise, LifeX Ventures aims to empower founders to scale their innovations and make a meaningful impact in their industries.
Investment Mandate
Investment Stages8
Asset Classes1
Geographical Focus
African markets1
Other stated markets37
Requirements
Innovative solutions in life sciences and healthcare sectors, Early-stage companies with validated concepts and clear market fit, Founders seeking hands-on support and strategic guidance
Stated Portfolio4
As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.
Is this you?
Claim this investor profile to manage your firm's information.
Claim this profileReport an error